Moreover, the use of an anti-NKG2D blocking mAb strongly decreased NK92-, NKd1- and NKd2-mediated killing of T1 melanoma cells (Supplementary Figure 4B), demonstrating that NKG2D is an important determinant for the lysis of T1 cells by NK cells. This evidence concerns the gene KLRK1 and melanoma.